India Life Sciences Fund IV — Form D/A
India Life Sciences Fund IV of GANDHINAGAR, GUJARAT, K7, a pooled investment fund, filed a Form D amendment with the SEC on 2024-06-24. $115.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-06-24
- Form: D/A
- Accession: 0001981456-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $115.6M
- Investors: 16
- Date of first sale: 2023-07-06
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-485350
Issuer
- Name: India Life Sciences Fund IV
- CIK: 0001981456
- Entity type: Business Trust
- Jurisdiction: INDIA
- Incorporated: 2023
- Address: SIGNATURE BUILDING, 1505B, 15/F, GANDHINAGAR, GUJARAT, K7, 382355
- Phone: 91-402-354-1305
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Hariharnath Buggana | Executive Officer | Gandhinagar, Gujarat, K7 |
Other filings by this issuer (1)
More